Stéphanie Klein

1.2k total citations
28 papers, 680 citations indexed

About

Stéphanie Klein is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, Stéphanie Klein has authored 28 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Cell Biology and 5 papers in Cancer Research. Recurrent topics in Stéphanie Klein's work include Cellular transport and secretion (4 papers), Multiple Sclerosis Research Studies (3 papers) and DNA Repair Mechanisms (2 papers). Stéphanie Klein is often cited by papers focused on Cellular transport and secretion (4 papers), Multiple Sclerosis Research Studies (3 papers) and DNA Repair Mechanisms (2 papers). Stéphanie Klein collaborates with scholars based in United States, United Kingdom and Germany. Stéphanie Klein's co-authors include Frédéric Luton, Michel Franco, Pierre Teilhard de Chardin, Mariagrazia Partisani, A. Robert MacLeod, Wolfgang Baumgärtner, Eric Macia, Brett P. Monia, Alexey S. Revenko and Paul D. Lyne and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Stéphanie Klein

23 papers receiving 666 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stéphanie Klein United States 13 420 159 76 73 66 28 680
Frida Danielsson Sweden 7 367 0.9× 116 0.7× 74 1.0× 67 0.9× 81 1.2× 12 632
Anna Pistocchi Italy 20 599 1.4× 155 1.0× 114 1.5× 83 1.1× 62 0.9× 57 1.0k
Souichi Kurita Japan 15 368 0.9× 315 2.0× 64 0.8× 68 0.9× 48 0.7× 18 741
João Filipe Barroso Norway 9 541 1.3× 140 0.9× 56 0.7× 36 0.5× 57 0.9× 11 793
Minh M. Nguyen United States 14 467 1.1× 143 0.9× 84 1.1× 99 1.4× 57 0.9× 25 765
Timothy J. Manning United States 11 599 1.4× 176 1.1× 61 0.8× 50 0.7× 48 0.7× 13 934
Caterina Di Ciano‐Oliveira Canada 13 583 1.4× 360 2.3× 80 1.1× 51 0.7× 41 0.6× 22 939
D Muir United Kingdom 9 289 0.7× 96 0.6× 43 0.6× 41 0.6× 84 1.3× 16 731
Francisco Rivero United Kingdom 18 456 1.1× 496 3.1× 55 0.7× 49 0.7× 42 0.6× 42 937
Sivaraman Natarajan United States 14 511 1.2× 130 0.8× 165 2.2× 84 1.2× 162 2.5× 19 865

Countries citing papers authored by Stéphanie Klein

Since Specialization
Citations

This map shows the geographic impact of Stéphanie Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphanie Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphanie Klein more than expected).

Fields of papers citing papers by Stéphanie Klein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphanie Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphanie Klein. The network helps show where Stéphanie Klein may publish in the future.

Co-authorship network of co-authors of Stéphanie Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphanie Klein. A scholar is included among the top collaborators of Stéphanie Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphanie Klein. Stéphanie Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prakash, Thazha P., Adam E. Mullick, Jinghua Yu, et al.. (2025). Discovery of long-acting APOC3 siRNA for treating patients with hypertriglyceridemia. Nucleic Acids Research. 53(20).
2.
3.
4.
Klein, Stéphanie, et al.. (2021). The effect of treatment with pimobendan in dogs with preclinical mitral valve disease – a placebo-controlled double-blinded crossover study. BMC Veterinary Research. 17(1). 310–310. 3 indexed citations
5.
Puttaraju, M., Michaela Jackson, Stéphanie Klein, et al.. (2021). Systematic screening identifies therapeutic antisense oligonucleotides for Hutchinson–Gilford progeria syndrome. Nature Medicine. 27(3). 526–535. 45 indexed citations
6.
Velasco, Marco A. De, Kazuko Sakai, Yuji Hatanaka, et al.. (2019). Targeting castration-resistant prostate cancer with androgen receptor antisense oligonucleotide therapy. JCI Insight. 4(17). 31 indexed citations
7.
Kim, Youngsoo, Minji Jo, Joanna Schmidt, et al.. (2019). Enhanced Potency of GalNAc-Conjugated Antisense Oligonucleotides in Hepatocellular Cancer Models. Molecular Therapy. 27(9). 1547–1557. 49 indexed citations
8.
9.
Ross, Sarah J., Alexey S. Revenko, Lyndsey Hanson, et al.. (2017). Targeting KRAS-dependent tumors with AZD4785, a high-affinity therapeutic antisense oligonucleotide inhibitor of KRAS. Science Translational Medicine. 9(394). 143 indexed citations
10.
Redfern, William S., Claire Grant, David J. Simpson, et al.. (2017). Automated recording of home cage activity and temperature of individual rats housed in social groups: The Rodent Big Brother project. PLoS ONE. 12(9). e0181068–e0181068. 64 indexed citations
11.
Klein, Stéphanie & Jean‐François Dufour. (2017). Nonalcoholic fatty liver disease and hepatocellular carcinoma. PubMed. 4(3). 83–98. 10 indexed citations
12.
Klein, Stéphanie, et al.. (2015). Reproductive senescence, fertility and reproductive tumour profile in ageing female Han Wistar rats. Experimental and Toxicologic Pathology. 68(2-3). 143–147. 3 indexed citations
13.
Seehusen, Frauke, Stéphanie Klein, Reiner Ulrich, et al.. (2012). Periventricular Demyelination and Axonal Pathology Is Associated with Subependymal Virus Spread in a Murine Model for Multiple Sclerosis. Intervirology. 55(6). 401–416. 31 indexed citations
14.
Herder, Vanessa, Ingo Gerhauser, Stéphanie Klein, et al.. (2012). Interleukin-10 expression during the acute phase is a putative prerequisite for delayed viral elimination in a murine model for multiple sclerosis. Journal of Neuroimmunology. 249(1-2). 27–39. 28 indexed citations
15.
Klein, Stéphanie, Michael Wendt, Wolfgang Baumgärtner, & Peter Wohlsein. (2009). Systemic Toxoplasmosis and Concurrent Porcine Circovirus-2 Infection in a Pig. Journal of Comparative Pathology. 142(2-3). 228–234. 14 indexed citations
16.
Klein, Stéphanie, Mariagrazia Partisani, Michel Franco, & Frédéric Luton. (2008). EFA6 Facilitates the Assembly of the Tight Junction by Coordinating an Arf6-dependent and -independent Pathway. Journal of Biological Chemistry. 283(44). 30129–30138. 18 indexed citations
17.
Seehusen, Frauke, Annika Lehmbecker, Christina Puff, et al.. (2008). Listeria monocytogenes Septicaemia and Concurrent Clostridial Infection in an Adult Alpaca (Lama pacos). Journal of Comparative Pathology. 139(2-3). 126–129.
18.
Klein, Stéphanie, Michel Franco, Pierre Teilhard de Chardin, & Frédéric Luton. (2006). Role of the Arf6 GDP/GTP Cycle and Arf6 GTPase-activating Proteins in Actin Remodeling and Intracellular Transport. Journal of Biological Chemistry. 281(18). 12352–12361. 54 indexed citations
19.
Klein, Stéphanie, Michel Franco, Pierre Teilhard de Chardin, & Frédéric Luton. (2005). AlFx affects the formation of focal complexes by stabilizing the Arf‐GAP ASAP1 in a complex with Arf1. FEBS Letters. 579(25). 5741–5745. 8 indexed citations
20.
Luton, Frédéric, Stéphanie Klein, Jean‐Paul Chauvin, et al.. (2003). EFA6, Exchange Factor for ARF6, Regulates the Actin Cytoskeleton and Associated Tight Junction in Response to E-Cadherin Engagement. Molecular Biology of the Cell. 15(3). 1134–1145. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frida Danielsson Breakdown of academic impact, for papers by Anna Pistocchi Breakdown of academic impact, for papers by Souichi Kurita Breakdown of academic impact, for papers by João Filipe Barroso Breakdown of academic impact, for papers by Minh M. Nguyen Breakdown of academic impact, for papers by Timothy J. Manning Breakdown of academic impact, for papers by Caterina Di Ciano‐Oliveira Breakdown of academic impact, for papers by D Muir Breakdown of academic impact, for papers by Francisco Rivero Breakdown of academic impact, for papers by Sivaraman Natarajan
Rankless by CCL
2026